Patent: 10,800,846
✉ Email this page to a colleague
Summary for Patent: 10,800,846
Title: | PD-1/PD-L1 inhibitors for the treatment of cancer |
Abstract: | The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1. |
Inventor(s): | Cuillerot; Jean-Marie (Somerville, MA), von Heydebreck; Anja (Darmstadt, DE), Yuan; Guojun (Winchester, MA) |
Assignee: | MERCK PATENT GMBH (Darmstadt, DE) PFIZER INC. (New York, NY) |
Application Number: | 15/553,437 |
Patent Claims: | see list of patent claims |
Details for Patent 10,800,846
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emd Serono, Inc. | BAVENCIO | avelumab | Injection | 761049 | 03/23/2017 | ⤷ Try a Trial | 2035-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |